Key stats
About Invesco Pharmaceuticals ETF
Home page
Inception date
Jun 23, 2005
Structure
Open-Ended Fund
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
Invesco Capital Management LLC
Distributor
Invesco Distributors, Inc.
PJP uses a quant-driven methodology to select and weight pharmaceutical companies based on fundamental and risk factors. Specifically, the fund holds about 30 US stocks that are evaluated based on five factors: price momentum, earnings momentum, quality, management action, and value. Although some of the major names are represented in the portfolio, PJPs multi-factor selection process and tier-weighting scheme tilts the fund toward mid and small-caps resulting in a low overall weighted average market cap. It therefore reduces concentrations in mega-caps and evenly weights the group of companies across size. Still, its small portfolio takes concentrated stakes in some leading names. The fund and the index are rebalanced and reconstituted quarterly in February, May, August and November. Prior to August 28, 2023, the fund traded under the name Invesco Dynamic Pharmaceuticals ETF.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.98%
Health Technology99.98%
Bonds, Cash & Other0.02%
Mutual fund0.02%
Stock breakdown by region
North America94.47%
Europe5.53%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
PJP top holdings are Abbott Laboratories and Gilead Sciences, Inc., occupying 5.39% and 5.31% of the portfolio correspondingly.
PJP last dividends amounted to 0.27 USD. The quarter before, the issuer paid 0.22 USD in dividends, which shows a 18.23% increase.
PJP assets under management is 240.11 M USD. It's risen 4.52% over the last month.
PJP fund flows account for −36.44 M USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, PJP pays dividends to its holders with the dividend yield of 1.14%. The last dividend (Mar 28, 2025) amounted to 0.27 USD. The dividends are paid quarterly.
PJP shares are issued by Invesco Ltd. under the brand Invesco. The ETF was launched on Jun 23, 2005, and its management style is Passive.
PJP expense ratio is 0.56% meaning you'd have to pay 0.56% of your investment to help manage the fund.
PJP follows the Dynamic Pharmaceutical Intellidex Index (AMEX). ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
PJP invests in stocks.
PJP price has risen by 1.90% over the last month, and its yearly performance shows a −1.93% decrease. See more dynamics on PJP price chart.
NAV returns, another gauge of an ETF dynamics, showed a −8.24% decrease in three-month performance and has decreased by −0.60% in a year.
NAV returns, another gauge of an ETF dynamics, showed a −8.24% decrease in three-month performance and has decreased by −0.60% in a year.
PJP trades at a premium (0.11%) meaning the ETF is trading at a higher price than the calculated NAV.